These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 12573592

  • 1. Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gamma.
    Stahl-Hennig C, Gundlach BR, Dittmer U, ten Haaft P, Heeney J, Zou W, Emilie D, Sopper S, Uberla K.
    Virology; 2003 Jan 20; 305(2):473-85. PubMed ID: 12573592
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
    Connor RI, Montefiori DC, Binley JM, Moore JP, Bonhoeffer S, Gettie A, Fenamore EA, Sheridan KE, Ho DD, Dailey PJ, Marx PA.
    J Virol; 1998 Sep 20; 72(9):7501-9. PubMed ID: 9696847
    [Abstract] [Full Text] [Related]

  • 5. IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaques.
    Boyer JD, Nath B, Schumann K, Curley E, Manson K, Kim J, Weiner DB.
    Int J Parasitol; 2002 May 20; 32(5):543-50. PubMed ID: 11943227
    [Abstract] [Full Text] [Related]

  • 6. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques.
    Abel K, La Franco-Scheuch L, Rourke T, Ma ZM, De Silva V, Fallert B, Beckett L, Reinhart TA, Miller CJ.
    J Virol; 2004 Jan 20; 78(2):841-54. PubMed ID: 14694116
    [Abstract] [Full Text] [Related]

  • 7. Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery.
    Mansfield K, Lang SM, Gauduin MC, Sanford HB, Lifson JD, Johnson RP, Desrosiers RC.
    J Virol; 2008 Apr 20; 82(8):4135-48. PubMed ID: 18272584
    [Abstract] [Full Text] [Related]

  • 8. Augmentation of antigen-specific cytokine responses in the early phase of vaccination with a live-attenuated simian/human immunodeficiency chimeric virus expressing IFN-gamma.
    Iida T, Kuwata T, Ui M, Suzuki H, Miura T, Ibuki K, Takahashi H, Yamamoto T, Imanishi J, Hayami M, Kita M.
    Arch Virol; 2004 Apr 20; 149(4):743-57. PubMed ID: 15045561
    [Abstract] [Full Text] [Related]

  • 9. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS, Park KS, Sauermann U, Franz M, Norley S, Wilfingseder D, Stoiber H, Fagrouch Z, Heeney J, Hunsmann G, Stahl-Hennig C, Sung YC.
    Vaccine; 2006 Mar 10; 24(11):1811-20. PubMed ID: 16274888
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge.
    Busch M, Abel K, Li J, Piatak M, Lifson JD, Miller CJ.
    Vaccine; 2005 Jul 01; 23(31):4036-47. PubMed ID: 15963361
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Conditionally-live attenuated SIV upregulates global T effector memory cell frequency under replication permissive conditions.
    Manoussaka MS, Berry N, Ferguson D, Stebbings R, Robinson M, Ham C, Page M, Li B, Das AT, Berkhout B, Almond N, Cranage MP.
    Retrovirology; 2013 Jun 05; 10():59. PubMed ID: 23738926
    [Abstract] [Full Text] [Related]

  • 18. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK, Das J, Musich TA, Demberg T, Weiner JA, Venzon DJ, Mohanram V, Vargas-Inchaustegui DA, Tuero I, Ackerman ME, Alter G, Robert-Guroff M.
    J Virol; 2018 Oct 01; 92(19):. PubMed ID: 30021899
    [Abstract] [Full Text] [Related]

  • 19. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
    Egan MA, Charini WA, Kuroda MJ, Schmitz JE, Racz P, Tenner-Racz K, Manson K, Wyand M, Lifton MA, Nickerson CE, Fu T, Shiver JW, Letvin NL.
    J Virol; 2000 Aug 01; 74(16):7485-95. PubMed ID: 10906202
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.